نتایج جستجو برای: t cell vaccination

تعداد نتایج: 2220123  

Journal: :The Journal of clinical investigation 2006
Rachel H McMahan Jennifer A McWilliams Kimberly R Jordan Steven W Dow Darcy B Wilson Jill E Slansky

One approach to enhancing the T cell response to tumors is vaccination with mimotopes, mimics of tumor epitopes. While mimotopes can stimulate proliferation of T cells that recognize tumor-associated antigens (TAAs), this expansion does not always correlate with control of tumor growth. We hypothesized that vaccination with mimotopes of optimal affinity in this interaction will improve antitumo...

Journal: :European Journal of Immunology 2021

HBV vaccination is recommend for hemodialysis patients, but only 50–60% of the patients show seroconversion. vaccine-induced generation reactive T and B cells could be detected regardless their capacity to mount a serological response, indicating that without seroconversion are potentially protected by HBV-reactive cell pool.

Journal: :Journal of immunology 2002
Thorsten U Vogel Helen Horton Deborah H Fuller Donald K Carter Kathy Vielhuber David H O'Connor Tim Shipley Jim Fuller Gerd Sutter Volker Erfle Nancy Wilson Louis J Picker David I Watkins

Evidence suggests that cellular immune responses play a crucial role in the control of HIV and SIV replication in infected individuals. Several vaccine strategies have therefore targeted these CD8(+) and CD4(+) responses. Whether vaccination induces the same repertoire of responses seen after infection is, however, a key unanswered question in HIV vaccine development. We therefore compared the ...

Journal: :Journal of immunology 2002
Mark P Rubinstein Andre N Kadima Mohamed L Salem Christophe L Nguyen William E Gillanders David J Cole

The systemic administration of IL-2 can act as a potent adjuvant for T cell-directed vaccine strategies. However, not only is the administration of IL-2 potentially toxic, but recent evidence suggests that it may also paradoxically limit the duration and magnitude of the cytotoxic T cell response. A recently identified cytokine, IL-15, shares many properties with IL-2 and may provide a preferen...

2016
Christabel Kelly Leo Swadling Stefania Capone Anthony Brown Rachel Richardson John Halliday Annette von Delft Ye Oo David Mutimer Ayako Kurioka Felicity Hartnell Jane Collier Virginia Ammendola Mariarosaria Del Sorbo Fabiana Grazioli Maria Luisa Esposito Stefania Di Marco Loredana Siani Cinzia Traboni Adrian V.S. Hill Stefano Colloca Alfredo Nicosia Riccardo Cortese Antonella Folgori Paul Klenerman Eleanor Barnes

UNLABELLED Adenoviral vectors encoding hepatitis C virus (HCV) nonstructural (NS) proteins induce multispecific, high-magnitude, durable CD4(+) and CD8(+) T-cell responses in healthy volunteers. We assessed the capacity of these vaccines to induce functional HCV-specific immune responses and determine T-cell cross-reactivity to endogenous virus in patients with chronic HCV infection. HCV genoty...

Journal: :Cancer research 2001
T Teshima N Mach G R Hill L Pan S Gillessen G Dranoff J L Ferrara

Allogeneic bone marrow transplantation (BMT) is currently restricted to hematological malignancies because of a lack of antitumor activity against solid cancers. We have tested a novel treatment strategy to stimulate specific antitumor activity against a solid tumor after BMT by vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor (GM-CS...

2012
Rose-Minke Schure Lia de Rond Kemal Öztürk Lotte Hendrikx Elisabeth Sanders Guy Berbers Anne-Marie Buisman

UNLABELLED Here we report the first evaluation of T-cell responses upon a second acellular pertussis booster vaccination in Dutch children at 9 years of age, 5 years after a preschool booster vaccination. Blood samples of children 9 years of age were studied longitudinally until 1 year after the second aP booster and compared with those after the first aP booster in children 4 and 6 years of ag...

Journal: :Blood 2009
Joshua D Brody Matthew J Goldstein Debra K Czerwinski Ronald Levy

Ex vivo-expanded tumor-infiltrating lymphocytes infused into lymphodepleted recipients has clear antitumor efficacy. More practical sources of such antitumor lymphocytes would broaden the application of this approach. Previously, we described an in situ vaccination combining chemotherapy with intratumoral injection of CpG-enriched oligonucleotides, which induced T-cell immunity against establis...

2014
Debapriya Bhattacharya Ved Prakash Dwivedi Santosh Kumar Madhava C. Reddy Luc Van Kaer Prashini Moodley Gobardhan Das

Tuberculosis affects nine million individuals and kills almost two million people every year. The only vaccine available, Bacillus Calmette-Guerin (BCG), has been used since its inception in 1921. Although BCG induces host-protective T helper 1 (Th1) cell immune responses, which play a central role in host protection, its efficacy is unsatisfactory, suggesting that additional methods to enhance...

2016
Muhammed O Afolabi Alfred B Tiono Uche J Adetifa Jean Baptiste Yaro Abdoulie Drammeh Issa Nébié Carly Bliss Susanne H Hodgson Nicholas A Anagnostou Guillaume S Sanou Ya Jankey Jagne Oumarou Ouedraogo Casimir Tamara Nicolas Ouedraogo Mirielle Ouedraogo Jainaba Njie-Jobe Amidou Diarra Christopher JA Duncan Riccardo Cortese Alfredo Nicosia Rachel Roberts Nicola K Viebig Odile Leroy Alison M Lawrie Katie L Flanagan Beate Kampman Philip Bejon Egeruan B Imoukhuede Katie J Ewer Adrian VS Hill Kalifa Bojang Sodiomon B Sirima

Malaria remains a significant global health burden and a vaccine would make a substantial contribution to malaria control. Chimpanzee Adenovirus 63 Modified Vaccinia Ankara Multiple epitope thrombospondin adhesion protein (ME-TRAP) and vaccination has shown significant efficacy against malaria sporozoite challenge in malaria-naive European volunteers and against malaria infection in Kenyan adul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید